Home › Products › Infectious Disease › Tromlieva 50mg Tablet
Tromlieva 50mg Tablet
Salt Composition: ELTROMBOPAG
- Manufacturer: Allieva Pharma Pvt. Ltd.
- Pack Size: 28 TABLET(s) IN A BOX
- Dosage Form: TABLET
- Strength: 50MG
- Prescription Required
- Storage: Store Tromlieva 50mg Tablet at room temperature (25°C). Keep the medicine out of reach of children and pets.
₹4500.00₹22500.00
Inclusive of all taxes
Product Introduction
Tromlieva 50mg Tablet is an anticoagulant belonging to the thrombopoietin (TPO) receptor agonist class, containing the active ingredient Eltrombopag. It is indicated for low platelet counts in patients with primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells essential for clotting and protection of blood vessel walls. Low platelet levels can result in severe bleeding and bruising. The tablet is also used in adults to treat low blood counts caused by severe aplastic anaemia, a serious blood disorder occurring when bone marrow fails to produce sufficient new blood cells.
This drug is contraindicated in individuals with known hypersensitivity or allergic reactions to Eltrombopag or its components. Allergic reactions may range from mild to severe, including rash, itching, swelling, dizziness, or difficulty breathing. Tromlieva 50mg Tablet is contraindicated in patients with severe liver impairment or active liver disease. The drug can cause hepatotoxicity, indicated by increased liver enzymes and bilirubin levels. Use in severe liver disease can further worsen liver function; caution is advised.
Your doctor will recommend screening for cataracts. Regular eye testing should be arranged if you do not have routine tests. You may also be screened for bleeding in or around your retina, the light-sensitive layer at the back of the eye. If you discontinue this tablet, your platelet count is likely to decrease again within several days. Platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high platelet count may increase the risk of blood clotting, though clots can form at normal or even low counts. Your doctor will adjust your dose to ensure platelet count does not become excessively high.
Do not take this tablet with dairy products or drinks, as calcium affects medicine absorption. Use effective birth control during treatment; inform your doctor if you become pregnant. Tromlieva 50mg Tablet is not advised for children under one year with ITP. It is not recommended for patients under 18 years with low platelet counts caused by hepatitis C or severe aplastic anaemia.
Inform your doctor of all medicines you are taking, have recently taken, or might take, including over-the-counter medicines and vitamins.
Uses
Tromlieva 50mg Tablet is used to treat, Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection Severe aplastic anemia
How it works
Eltrombopag stimulates megakaryocytes (the large bone marrow cells) responsible for producing platelets. By raising the number of platelets in the blood, this drug prevents bleeding and bruising.
How to Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of the drug based on the disease condition and other factors. Always take a Tromlieva 50mg tablets prescribed by your doctor. Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Nausea Diarrhea, abdominal pain Common cold Cough Respiratory tract infection Back pain High temperature, cough Loss of appetite Hair loss Swelling in feet or hands Headache, dizziness Mouth and throat pain Joint pain
Expert Tips
Ensure that in the 2 hours after or 4 hours before you take this medication, you donât consume dairy foods (such as cheese or butter), milk or milkshakes, antacids, and supplements containing iron, aluminium, magnesium, calcium, selenium, zinc, or calcium. If you forget to take Tromlieva 50mg Tablet, take your next dose at the usual time. Do not take more than one dose of this drug daily. Donât stop taking this tablet without talking to your doctor. If your doctor advises you to stop treatment, your platelet count will be checked each week for four weeks. If you have any doubts regarding the use of this medicine, ask your doctor.
References
- Novartis Pharmaceuticals UK Limited, Electronic medicines compendium (EMC), [ Revised on Jan 2022] [Accessed on 22 May 2023], https://www.medicines.org.uk/emc/files/pil.508.pdf
- GlaxoSmithKline, US Food and Drug Administration, [ Revised on October 2008] [Accessed on 22 May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022291lbl.pdf
- Revolade, Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/revolade-epar-product-information_en.pdf [Accessed on 22 May 2023].
Safety Advice
Pregnancy: unsafe Tromlieva 50mg Tablet is not recommended for pregnant patients because it may cause fetal harm. You must inform your doctor if you are pregnant, suspecting, or planning to get pregnant during the treatment.
Lungs: Consult your doctor It is unknown whether Tromlieva 50mg Tablet can be prescribed for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: Consult your doctor It is not known whether Tromlieva 50mg Tablet passes into breast milk. If you are breastfeeding or planning to breastfeed, tell your doctor.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.